Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Larcher

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Cell Science|November 24, 1999
Polyglutamylation and polyglycylation of alpha- and beta-tubulins during in vitro ciliated cell differentiation of human respiratory epithelial cellsK Million, J Larcher, J Laoukili, et al.
Journal De Radiologie|December 1, 1979
[The value of arteriography in the diagnosis and treatment of post-traumatic secondary impotence (author's transl)]D Régent, J L'Hermite, J J Larcher, et al.
ESMO Gastrointestinal Oncology|April 17, 2026
Impact of nutritional risk screening on outcomes of first-line treatment in metastatic esophagogastric adenocarcinoma: a secondary analysis of the AIO-MATEO trialR Stelmach, S Lorenzen, T J Ettrich, et al.
ESMO Open|June 4, 2023
S-1 maintenance therapy in Caucasian patients with metastatic esophagogastric adenocarcinoma-final results of the randomized AIO MATEO phase II trialG Stocker, S Lorenzen, T Ettrich, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Cell Science|November 24, 1999
Polyglutamylation and polyglycylation of alpha- and beta-tubulins during in vitro ciliated cell differentiation of human respiratory epithelial cellsK Million, J Larcher, J Laoukili, et al.
Journal De Radiologie|December 1, 1979
[The value of arteriography in the diagnosis and treatment of post-traumatic secondary impotence (author's transl)]D Régent, J L'Hermite, J J Larcher, et al.
ESMO Gastrointestinal Oncology|April 17, 2026
Impact of nutritional risk screening on outcomes of first-line treatment in metastatic esophagogastric adenocarcinoma: a secondary analysis of the AIO-MATEO trialR Stelmach, S Lorenzen, T J Ettrich, et al.
ESMO Open|June 4, 2023
S-1 maintenance therapy in Caucasian patients with metastatic esophagogastric adenocarcinoma-final results of the randomized AIO MATEO phase II trialG Stocker, S Lorenzen, T Ettrich, et al.
Pageof 1